Ameritas Investment Partners, Inc. Invitae Corp Transaction History

Ameritas Investment Partners, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $5,247 - $13,381	8,746 Added 50.93%	25,918 $15,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $2,850 - $12,945	1,500 Added 9.57%	17,172 $42,000
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $972 - $1,344	-40 Reduced 0.25%	15,672 $446,000
Q2 2021 Aug 06, 2021	BUY	$26.09 - $40.4 $153,304 - $237,390	5,876 Added 59.74%	15,712 $530,000
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $10,263 - $16,125	-361 Reduced 3.54%	9,836 $426,000
Q2 2020 Aug 05, 2020	BUY	$11.71 - $30.29 $28,209 - $72,968	2,409 Added 30.93%	10,197 $309,000
Q1 2020 May 13, 2020	BUY	$7.64 - $27.5 $2,880 - $10,367	377 Added 5.09%	7,788 $106,000
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $27,166 - $41,086	1,564 Added 26.75%	7,411 $174,000
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $4,568 - $11,046	429 Added 7.92%	5,847 $137,000
Q2 2018 Aug 13, 2018	BUY	$4.87 - $8.42 $9,744 - $16,848	2,001 Added 58.56%	5,418 $40,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,417	3,417 $33,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.